Dr. Reddy’s Laboratories Announces Launch of the Sputnik V vaccine inthe Indian Market

Dr. Reddy’s Laboratories Ltd. announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on 1stMay, 2021, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on 13th May, 2021. As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose of the vaccine was administered in Hyderabad today on14th May, 2021.

Further consignments of imported doses are expected overthe upcomingmonths.Subsequently, supply of the Sputnik V vaccine will commence from Indian manufacturing partners. The imported doses of the vaccine are presently priced at an MRP of Rs 948 + 5% GST per dose, with the possibility of a lower price point when local supply begins.The Companyis workingcloselywith its six manufacturing partners in India to fulfill regulatory requirements to ensure smooth and timely supply.

Dr. Reddy’s will work closely with stakeholders in the Government and private sector in India to ensure the widest possible reach of the Sputnik V vaccine as part of the national inoculation effort. This is a reaffirmation of the Company’s commitment to explore every avenue in the fight against the COVID-19 pandemic in India.

GV Prasad, Co-Chairman and Managing Director, said:“With the rising cases in India, vaccination isour most effective tool in our battle against COVID-19.Contributing to the vaccination drive in Indiais ourbiggest priorityright now to help Indians be healthy and safe.”

About Dr. Reddy’s:
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses -Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products –Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include –USA, India, Russia & CIS countries, and Europe.